MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
17.00
+0.87 (5.39%)
At close: Oct 24, 2025, 4:00 PM EDT
16.68
-0.32 (-1.88%)
After-hours: Oct 24, 2025, 7:57 PM EDT
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $760.16 million as of October 24, 2025. Its market cap has decreased by -1.30% in one year.
Market Cap
760.16M
Enterprise Value
535.91M
1-Year Change
-1.30%
Ranking
Category
Stock Price
$17.00
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $760.16M, an increase of 49.15%. That is a compound annual growth rate of 43.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 760.16M | 23.43% |
| Dec 31, 2024 | 615.88M | 20.84% |
| Sep 13, 2024 | 509.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 746.45B |
| Johnson & Johnson | 459.11B |
| AbbVie | 402.78B |
| UnitedHealth Group | 329.49B |
| AstraZeneca | 258.15B |
| Novartis AG | 254.23B |
| Novo Nordisk | 236.86B |
| Abbott Laboratories | 222.27B |